EyePoint Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary

EyePoint

09/08/2024 14:31

* EyePoint Pharmaceuticals Inc  EYPT.OQ  reported a
quarterly
adjusted loss of 58 cents​​ per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of -61 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 52 cents per
share. Wall Street expected results to range from -66 cents
to -34 cents per share.
    * Revenue rose 4.1% to $9.48 million from a year ago;
analysts
expected $9.59 million. 
    * EyePoint Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 58 cents​.
    * The company reported a quarterly loss of $30.83 million.
    * EyePoint Pharmaceuticals Inc shares had risen by 5.3% this
quarter and lost 60.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for EyePoint
Pharmaceuticals Inc is $35.00 
This summary was machine generated from LSEG data August 9 at
01:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.52          -0.58          Missed
 Mar. 31 2024      -0.42          -0.55          Missed
 Dec. 31 2023      -0.49          -0.33          Beat
 Sep. 30 2023      -0.51          -0.33          Beat